PMID- 19256760 OWN - NLM STAT- MEDLINE DCOM- 20090528 LR - 20170308 IS - 2476-762X (Electronic) IS - 1513-7368 (Linking) VI - 9 IP - 4 DP - 2008 Oct-Dec TI - Molecular cytogenetic analysis of urothelial carcinomas using urine samples. PG - 687-90 AB - Urinary cells obtained from voided urine specimens of 46 patients with urothelial carcinomas (UCs) and 10 normal individuals were analyzed with 3 different centromeric fluorescence in situ hybridization (FISH) probes. The overall sensitivity of cytology was 48.9% compared to 95.7%with the FISH technique. The minimum values were found for stage Ta and grade 1 (90.5 and 89.4) and sensitivity of FISH in other stages and grades was 100%. Chromosome 3 demonstrated the most frequent chromosomal abnormality in all samples (43%), followed by chromosome 17 (32%) and chromosome 7 (25%). There was a statistically significant association between the number of cell abnormalities in chromosome 17 and the tumour stage (p value=0.02). No relationship was found between the type of chromosomal abnormality and grade. Thus feasibility and reliability of a FISH based approach was confirmed for detection of UC in urine samples. FAU - Ayati, M AU - Ayati M AD - Department of Urooncology, Imam Khomeini Hospital, Tehran, Iran. FAU - Tousi, V Najjaran AU - Tousi VN FAU - Sabokba, T AU - Sabokba T FAU - Vaziri-Nasab, H AU - Vaziri-Nasab H FAU - Mehrkhani, F AU - Mehrkhani F FAU - Jamshidian, H AU - Jamshidian H FAU - Dastan, J AU - Dastan J FAU - Mosavi-Jarrahi, A R AU - Mosavi-Jarrahi AR FAU - Ghaffari, S R AU - Ghaffari SR LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Thailand TA - Asian Pac J Cancer Prev JT - Asian Pacific journal of cancer prevention : APJCP JID - 101130625 SB - IM MH - Aged MH - Aged, 80 and over MH - Carcinoma, Transitional Cell/*genetics/*urine MH - Case-Control Studies MH - Chromosome Aberrations MH - Chromosomes, Human, Pair 17 MH - Chromosomes, Human, Pair 3 MH - Chromosomes, Human, Pair 7 MH - Cytodiagnosis/methods MH - Cytogenetic Analysis/*methods MH - Female MH - Humans MH - In Situ Hybridization, Fluorescence/*methods MH - Iran MH - Male MH - Middle Aged MH - Neoplasm Staging MH - Sampling Studies MH - Sensitivity and Specificity MH - Urinary Bladder Neoplasms/*genetics/*urine MH - Urine/*cytology EDAT- 2009/03/05 09:00 MHDA- 2009/05/29 09:00 CRDT- 2009/03/05 09:00 PHST- 2009/03/05 09:00 [entrez] PHST- 2009/03/05 09:00 [pubmed] PHST- 2009/05/29 09:00 [medline] PST - ppublish SO - Asian Pac J Cancer Prev. 2008 Oct-Dec;9(4):687-90.